Abstract
Purpose
In this study, protein-shell microspheres filled with a suspension of iron oxide nanoparticles in oil are demonstrated as multimodal contrast agents in magnetic resonance imaging (MRI), magnetomotive optical coherence tomography (MM-OCT), and ultrasound imaging. The development, characterization, and use of multifunctional multimodal microspheres are described for targeted contrast and therapeutic applications.
Procedures
A preclinical rat model was used to demonstrate the feasibility of the multimodal multifunctional microspheres as contrast agents in ultrasound, MM-OCT and MRI. Microspheres were functionalized with the RGD peptide ligand, which is targeted to αvβ3 integrin receptors that are over-expressed in tumors and atherosclerotic lesions.
Results
These microspheres, which contain iron oxide nanoparticles in their cores, can be modulated externally using a magnetic field to create dynamic contrast in MM-OCT. With the presence of iron oxide nanoparticles, these agents also show significant negative T2 contrast in MRI. Using ultrasound B-mode imaging at a frequency of 30 MHz, a marked enhancement of scatter intensity from in vivo rat mammary tumor tissue was observed for these targeted protein microspheres.
Conclusions
Preliminary results demonstrate multimodal contrast-enhanced imaging of these functionalized microsphere agents with MRI, MM-OCT, ultrasound imaging, and fluorescence microscopy, including in vivo tracking of the dynamics of these microspheres in real-time using a high-frequency ultrasound imaging system. These targeted oil-filled protein microspheres with the capacity for high drug-delivery loads offer the potential for local delivery of lipophilic drugs under image guidance.
References
Wang X, Yang L, Chen Z, Shin DM (2008) Application of nanotechnology to cancer therapy and imaging. CA Cancer J Clin 58:97–110
Moghimi SM, Hunter AC, Murray JC (2005) Nanomedicine: current status and future prospects. FASEB J 19:311–330
Boppart SA, Oldenburg AL, Xu C, Marks DL (2005) Optical probes and techniques for molecular contrast enhancement in coherence imaging. J Biomed Opt 10:041208
Lee TM, Toublan FJ, Sitafalwalla S et al (2003) Engineered microsphere contrast agents for optical coherence tomography. Opt Lett 28:1456–1458
McCarthy JR, Weissleder R (2008) Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug deliv Rev 60:1241–1251
Gao X, Gui Y, Levenson RM et al (2004) In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 22:969–976
Huang D, Swanson EA, Lin CP et al (1991) Optical coherence tomography. Science 254:1178–1181
Bouma BE, Tearney GJ (eds) (2002) Handbook of Optical Coherence Tomography. Marcel Dekker, New York, New York
Boppart SA, Bouma BE, Pitris C et al (1998) Intraoperative assessment of microsurgery with three-dimensional optical coherence tomography. Radiology 208:81–86
Nguyen FT, Zysk AM, Chaney EJ et al (2009) Intraoperative evaluation of breast tumor margins with optical coherence tomography. Cancer Res 69:8790–8796
Rao KD, Choma MA, Yazdanfar S et al (2003) Molecular contrast in optical coherence tomography by use of a pump-probe technique. Opt Lett 28:340–342
Xu C, Ye J, Marks DL, Boppart SA (2004) Near-infrared dyes as contrast-enhancing agents for spectroscopic optical coherence tomography. Opt Lett 29:1647–1649
Oldenburg AL, Hansen MN, Zweifel DA et al (2006) Plasmon-resonant gold nanorods as low backscattering albedo contrast agents for optical coherence tomography. Opt Express 14:6724–6738
Cang H, Sun T, Li Z-Y et al (2005) Gold nanocages as contrast agents for spectroscopic optical coherence tomography. Opt Lett 30:3048–3050
Barton JK, Hoying JB, Sullivan CJ (2002) Use of microbubbles as an optical coherence tomography contrast agent. Acad Radiol 9:S52–S55
Rapoport N, Gao Z, Kennedy A (2007) Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J Natl Cancer Inst 99:1095–1106
Kolbeck KJ (1999) Biomedical applications of protein microspheres, PhD Dissertation in Chemistry. University of Illinois at Urbana-Champaign, Urbana
Dibbern EM (2005) Core shell microspheres for biomedical applications, PhD Dissertation, Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois
Toublan FJJ, Boppart SA, Suslick KS (2006) Tumor targeting by surface-modified protein microspheres. J Am Chem. Soc.128:3472–3473
Oldenburg AL, Toublan FJ, Suslick KS et al (2005) Magnetomotive contrast for in vivo optical coherence tomography. Opt Express 13:6597–6614
Oldenburg AL, Gunther JR, Boppart SA (2005) Imaging magnetically labeled cells with magnetomotive optical coherence tomography. Opt Lett 30:747–749
Oldenburg AL, Crecea V, Rinne SA, Boppart SA (2008) Phase-resolved magnetomotive OCT for imaging nanomolar concentrations of magnetic nanoparticles in tissues. Opt Express 16:11525–11539
John R, Chaney EJ, Boppart SA (2010) Dynamics of magnetic nanoparticle-based contrast agents in tissues tracked using magnetomotive optical coherence tomography. IEEE J Sel Top Quantum Electron 16:691–697
John R, Rezaeipoor R, Adie SG et al (2010) In vivo magnetomotive optical molecular imaging using targeted magnetic nanoprobes. Proc Natl Acad Sci USA 107:8085–8090
Unger EC, McCreery TP, Sweitzer RH (1998) A novel ultrasound contrast agent with therapeutic properties. Acad Radiol 5:S247–S249
Unger EC, McCreery TP, Sweitzer RH et al (1998) Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent. Invest Radiol 33:886–892
Eliceiri BP, Cheresh DA (1999) The role of alpha v beta 3 integrins during angiogenesis. J Clin Invest 103:1227–1230
Hoshiga M, Alpers CE, Smith LL et al (1995) Alpha-v beta-3 integrin expression in normal and atherosclerotic artery. Circ Res 77:1129–1135
Pasqualini R, Koivunen E, Ruoslahti E (1997) α v integrins as receptors for tumor targeting by circulating ligands. Nat Biotechnol 15:542–546
Winter PM, Morawski AM, Caruthers SD et al (2003) Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v) beta(3)-integrin-targeted nanoparticles. Circulation 108:2270–2274
Acknowledgements
This research was supported in part by grants from the National Institutes of Health (Roadmap Initiative, NIBIB R21 EB005321, NIBIB R01 EB009073, and NCI RC1 CA147096).
Conflicts of Interest
Stephen A. Boppart receives royalties related to optical coherence tomography for patents licensed by the Massachusetts Institute of Technology. He is also co-founder of Diagnostic Photonics, Inc., a company developing Interferometric Synthetic Aperture Microscopy for medical applications, and he receives funding for sponsored research projects from Welch Allyn, Inc. and Samsung, Inc., related to optical imaging technologies. All other authors report no real or perceived conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
John, R., Nguyen, F.T., Kolbeck, K.J. et al. Targeted Multifunctional Multimodal Protein-Shell Microspheres as Cancer Imaging Contrast Agents. Mol Imaging Biol 14, 17–24 (2012). https://doi.org/10.1007/s11307-011-0473-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-011-0473-7